For example, it has been suggested that ABCG2, FECH, and HO‐1 could serve as indicators of treatment outcome for ALA-PDT of brain tumors, while in HNC, STAT3 could be used as a molecular marker of cumulative photoreaction therapy monitoring.77 This evidence concerns the gene FECH and brain neoplasm.